<?xml version='1.0' encoding='utf-8'?>
<document id="31228606"><sentence text="Generation of Human iPSC-Derived Intestinal Epithelial Cell Monolayers by CDX2 Transduction." /><sentence text="To develop an effective and safe orally administered drug, it is important to predict its intestinal absorption rate, intestinal first-pass effect, and drug-drug interactions of orally administered drugs" /><sentence text=" However, there is no existing model to comprehensively predict the intestinal pharmacokinetics and drug-response of orally administered drugs" /><sentence text=" In this study, we attempted to generate homogenous and functional intestinal epithelial cells from human induced pluripotent stem (iPS) cells for pharmaceutical research" /><sentence text="" /><sentence text="We generated almost-homogenous Villin- and zonula occludens-1 (ZO1)-positive intestinal epithelial cells by caudal-related homeobox transcription factor 2 (CDX2) transduction into human iPS cell-derived intestinal progenitor cells" /><sentence text="" /><sentence text="The drug absorption rates in human iPS cell-derived intestinal epithelial cell monolayers (iPS-IECM) were highly correlated with those in humans (R2=0" /><sentence text="91)" /><sentence text=" The expression levels of cytochrome P450 (CYP) 3A4, a dominant drug-metabolizing enzyme in the small intestine, in human iPS-IECM were similar to those in human small intestine in vivo" /><sentence text=" In addition, intestinal availability in human iPS-IECM (the fraction passing the gut wall: Fg=0" /><sentence text="73) was more similar to that in the human small intestine in vivo (Fg=0" /><sentence text="57) than to that in Caco-2 cells (Fg=0" /><sentence text="99), a human colorectal adenocarcinoma cell line" /><sentence text=" Moreover, the drug-drug interaction and drug-food interaction could be observed by using our human iPS-IECM in the presence of an inducer and inhibitor of CYP3A4, i" /><sentence text="e" /><sentence text=", rifampicin and grape fruit juice, respectively"><entity charOffset="2-12" id="DDI-PubMed.31228606.s17.e0" text="rifampicin" /></sentence><sentence text="" /><sentence text="Taking these results together, we succeeded in generating the human iPS-IECM that can be applied to various intestinal pharmacokinetics and drug-response tests of orally administered drugs" /><sentence text="" /></document>